---
title: "Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety screenings"
description: In this webinar, learn how iPSC-derived endothelial cells enable detailed understanding of drug effects on vascular function and vessel formation.
---

[Webinars ](https://www.ncardia.com/insights/webinars)

# [Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety screenings](https://www.ncardia.com/insights/webinars/webinar-the-potential-of-ipsc-derived-endothelial-cells-for-efficacy-and-safety-screenings)

 Written by [Jessica Koepke](https://www.ncardia.com/insights/webinars/author/jessica-koepke) | May 27, 2022

As endothelial cells are involved in many biological processes, they hold great potential for *in vitro* drug screening. However, there is a lack of scalable assays and a need for large-scale batches to bring higher reproducibility and accuracy during early and preclinical drug discovery.  
To meet these requirements, relevant *in vitro* models of the vasculature, amenable for high-throughput are needed. Human induced pluripotent stem cells (iPSC), differentiated into endothelial cells and manufactured at large scale, are a powerful tool to fulfill these needs.

Human iPSC-derived endothelial cells enable detailed understanding of drug effects on vascular function and angiogenesis that is key to identify and validate targets for treatments for a variety of diseases and evaluate drug-induced compound effects for safety screenings.

In this webinar, we present the potential of Ncardia's [iPSC-derived endothelial cell models](https://www.ncardia.com/discovery-services/modeling/vascular-endothelial-cells). We have developed a controlled process for large-scale manufacturing of iPSC-derived endothelial cells and scalable assays for [drug efficacy and safety screenings](https://www.ncardia.com/discovery-services/screening), with the aim of bringing better medicines to patients faster.

### In this webinar you will:

- Gain insights into the advantages of iPSC-based models versus primary cell models
- Learn how human iPSC-derived endothelial cells enable detailed understanding of drug effects on vascular function and vessel formation
- Discover future potential applications of iPSC-derived endothelial cells

[View full post](https://www.ncardia.com/insights/webinars/webinar-the-potential-of-ipsc-derived-endothelial-cells-for-efficacy-and-safety-screenings)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Jessica Koepke"
  },
  "dateModified" : "2022-08-29T08:44:49.852Z",
  "datePublished" : "2022-05-27T04:00:00Z",
  "headline" : "Webinar: The potential of iPSC-derived endothelial cells for efficacy and safety screenings",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1080,
    "url" : "https://25505018.fs1.hubspotusercontent-eu1.net/hubfs/25505018/Blog%20Featured%20Images/Featured%20image_webinar%201%20endothelial%20cells.png",
    "width" : 1920
  },
  "mainEntityOfPage" : "https://www.ncardia.com/insights/webinars/webinar-the-potential-of-ipsc-derived-endothelial-cells-for-efficacy-and-safety-screenings",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Webinars"
  }
}
```